Zevalin and Herpes simplex - a phase IV clinical study of FDA data

Summary:

Herpes simplex is reported as a side effect among people who take Zevalin (ibritumomab tiuxetan), especially for people who are male, 2-9 old, also take Busulfex, and have Burkitt lymphoma.

The phase IV clinical study analyzes which people have Herpes simplex when taking Zevalin. It is created by eHealthMe based on reports of 2,256 people who have side effects when taking Zevalin from the FDA, and is updated regularly.

What is Zevalin?

Zevalin has active ingredients of ibritumomab tiuxetan. eHealthMe is studying from 2,258 Zevalin users. Check the latest studies of Zevalin.

What is Herpes simplex?

Herpes simplex (herpes simplex is a common viral infection) is found to be associated with 715 drugs and 895 conditions by eHealthMe. Check the latest studies of Herpes simplex.

On Jul, 11, 2026

2,256 people reported to have side effects when taking Zevalin.
Among them, 49 people (2.17%) have Herpes simplex.

Among these 49 people:

What is the gender of people who have Herpes simplex when taking Zevalin? *

female: 2.44 %
male: 97.56 %

What is the age of people who have Herpes simplex when taking Zevalin? *

What are other drugs people take besides Zevalin? *

What are other side effects people have besides Herpes simplex? *

Sepsis (a severe blood infection that can lead to organ failure and death): 48 people, 97.96%
Respiratory Disorder (respiratory disease): 48 people, 97.96%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 48 people, 97.96%
Progressive Multifocal Leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells): 48 people, 97.96%
Mucosal Inflammation (infection of mucous membrane): 48 people, 97.96%
Meningitis Tuberculous (a bacterial infection of the membranes covering the brain and spinal cord (meninges)): 48 people, 97.96%
White Blood Cell Count Decreased: 1 person, 2.04%
Tonsillar Disorder (disease of tonsil): 1 person, 2.04%
Rashes (redness): 1 person, 2.04%
Rales (an abnormal respiratory sound characterized by fine crackles): 1 person, 2.04%

What are the existing conditions these people have? *

Burkitt Lymphoma (cancer of the lymphatic system): 49 people, 100.00%
Bone Marrow Conditioning Regimen: 42 people, 85.71%
Follicle Centre Lymphoma, Follicular Grade I, Ii, Iii: 1 person, 2.04%
Follicle Centre Lymphoma Diffuse Small Cell Lymphoma: 1 person, 2.04%

* Approximation only. Some reports may have incomplete information.

Do you take Zevalin and have Herpes simplex?

- Check whether Herpes simplex is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zevalin:

Zevalin (2,258 reports)

Herpes simplex treatments and more:

Herpes simplex (13,420 reports)

Browse all side effects of Zevalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Herpes simplex:

Herpes simplex (715 drugs)

Browse all the conditions that are associated with Herpes simplex:

Herpes simplex (895 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ibritumomab tiuxetan (the active ingredients of Zevalin) and Zevalin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.